Executive Board Changes at Merck KGaA, Darmstadt, Germany
- Kai Beckmann to assume responsibility for the Performance Materials business sector
- Walter Galinat takes over responsibility for the Darmstadt site, Procurement as well as Environment and Quality
The Personnel Committee of E. Merck KG, Darmstadt, Germany, has decided on changes in the responsibilities of the Executive Board of Merck KGaA, Darmstadt, Germany, effective September 1, 2017.
Walter Galinat (61) will hand over responsibility for the Performance Materials business of Merck KGaA, Darmstadt, Germany, to his Executive Board colleague Kai Beckmann (51). In return, Galinat will take on Executive Board responsibility for the Darmstadt site, Procurement as well as Environmental Protection, Quality and Safety.
“With these changes to the Executive Board, we are underscoring personnel continuity within the Board while setting the course for the future of Performance Materials,” said Johannes Baillou, Chairman of the Board of Partners of E. Merck KG, Darmstadt, Germany, and its Personnel Committee. In addition, in his new role Galinat will further advance both the construction and organizational preparations for the 350th anniversary celebration of Merck KGaA, Darmstadt, Germany, in 2018.
“Over the past decade, Walter Galinat has led Performance Materials from one success to the next. We are very grateful to him for this. At the same time, we are pleased to continue building on his vast wealth of experience,” said Baillou. “As an experienced member of the Group’s Executive Board, Kai Beckmann has extensive business, technological and international expertise, among other things from the very important Asian market. For him and for Merck KGaA, Darmstadt, Germany, the aim now is to build on the long and successful development of Performance Materials, leading it into the future in times of increasingly dynamic developments in the liquid crystals market.”
Belén Garijo (57), CEO Healthcare, will additionally take over Executive Board responsibility for Group Human Resources from Kai Beckmann. Udit Batra (46), CEO Life Science, will be responsible for Business Technology, in other words the IT landscape of the Group. In addition to his role as Chief Financial Officer, Marcus Kuhnert (48) will be responsible for the Group’s Business Services, a newly formed unit.
CVs of the Members of the Executive Board can be found here.
All Merck KGaA, Darmstadt, Germany, press releases are distributed by e-mail at the same time they become available on the EMD Group Website. In case you are a resident of the USA or Canada please go to www.emdgroup.com/subscribe to register again for your online subscription of this service as our newly introduced geo-targeting requires new links in the email. You may later change your selection or discontinue this service.
About Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany, is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2016, Merck KGaA, Darmstadt, Germany, generated sales of € 15.0 billion in 66 countries.
Founded in 1668, Merck KGaA, Darmstadt, Germany, is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck KGaA, Darmstadt, Germany, holds the global rights to the „Merck” name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.
Merck KGaA, Darmstadt, Germany, has acquired Massachusetts-based Erbi Biosystems, a developer of the 2 ml micro-bioreactor platform technology, known as the “Breez™”.